Skip to content

NOTICIERO VOIDVOID TERMINAL

AI Web3 Crypto Stocks Finance Macro Prediction Markets Technology Markets Newsletter

PRO

Front page › Markets

Markets

JPMorgan upgrades Genmab stock rating on drug trial outlook

Investing.com27 Oct 2026, 08:21 UTC

Read the full story at Investing.com

Related

Why is Exosens stock sliding today? Investing.com
Why is Cadence Design Systems stock climbing today? Investing.com
Vend Marketplaces stock rises on cost savings upgrade and buyback plans Investing.com
Why is Alfa Laval stock climbing today? Investing.com
¿Por qué caen hoy las acciones de Standard Chartered? Investing.com España
Las acciones de Shoezone caen casi un 24% tras pérdidas anuales Investing.com España
U.S. Pensions Are Riding the A.I. Wave. For Better or Worse. The New York Times
Acciones de Cadence suben antes de apertura tras buenos resultados del T3 Investing.com España

Economy & Central Banks · AI · Markets · Crypto · Web3 · Stocks · Technology · Finance · Commodities · Currencies · Geopolitics · All news · About · Editorial policy · Privacy

NOTICIERO VOID ·

Economy · Markets · Crypto · Commodities · Currencies · Geopolitics · About · Editorial policy · Privacy · RSS

Data: FRED (St. Louis Fed), U.S. Treasury FiscalData, Federal Reserve, ECB, BEA, CoinGecko, DefiLlama, GeckoTerminal, OKX, Solana RPC and publisher RSS feeds. Headlines link to the original publishers. Keyboard: g then t/m/n/c to jump · / search.